Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/15/2024 | Buy → Neutral | Sidoti | |
| 10/9/2023 | $39.00 | Buy | B. Riley Securities |
| 6/15/2023 | $3.40 | Overweight | Cantor Fitzgerald |
| 5/11/2022 | $27.00 | Buy | Lake Street |
Kimball Electronics, Inc. (NASDAQ:KE) today announced the Company is intensifying its focus on strategic development with the appointment of a new member to its leadership team. Andrew D. Regrut, Treasurer and Investor Relations Officer, will now also lead the strategic development efforts of the Company. Commenting on Mr. Regrut's expanded role, Jana T. Croom, Chief Financial Officer, stated, "I'm thrilled to be announcing Andy's promotion and addition to our leadership team. He has been instrumental in our recent efforts to optimize debt levels through improved working capital management and global cash movement. We look for his energy and intensity to elevate our focus on strategic d
Kimball Electronics, Inc. (NASDAQ:KE) today announced the Company will participate in the 7th Annual Wolfe Research Healthcare Conference, which is being held November 17-19, 2025, at the Wolfe Research offices in New York, NY. Richard D. Phillips, Chief Executive Officer, and Jana T. Croom, Chief Financial Officer, are scheduled to present on Tuesday, November 18, 2025, at 10:40 a.m. Eastern Time. A webcast of the presentation will be available on the Events & Presentations tab in the Investor Relations section of the Company website, at investors.kimballelectronics.com/events-and-presentations/events. If you are unable to attend the live webcast, an archive will be available in this sam
First Quarter 2026 Highlights Revenue of $365.6 million, with strong year-over-year sales growth in the medical end-market vertical Operating income of $14.5 million, or 4.0% of net sales, adjusted OI of 4.8%, up 140 bps year-over-year Net income of $10.1 million, or $0.40 per diluted share, adjusted EPS of $0.49, more than double Q1 fiscal 2025 Cash from operations of $8.1 million, the seventh consecutive quarter of positive cash generation Debt of $138.0 million, down $9.5 million in the quarter, and borrowing capacity of $294.3 million Cash Conversion Days of 83, the lowest level in 3 years Invested $1.5 million to repurchase 49,000 shares of common stock Kimball Electron
Sidoti downgraded Kimball Electronics from Buy to Neutral
B. Riley Securities initiated coverage of Kimball Electronics with a rating of Buy and set a new price target of $39.00
Cantor Fitzgerald initiated coverage of Kimball Electronics with a rating of Overweight and set a new price target of $3.40
3 - Kimball Electronics, Inc. (0001606757) (Issuer)
4 - Kimball Electronics, Inc. (0001606757) (Issuer)
4 - Kimball Electronics, Inc. (0001606757) (Issuer)
8-K - Kimball Electronics, Inc. (0001606757) (Filer)
10-Q - Kimball Electronics, Inc. (0001606757) (Filer)
8-K - Kimball Electronics, Inc. (0001606757) (Filer)
First Quarter 2026 Highlights Revenue of $365.6 million, with strong year-over-year sales growth in the medical end-market vertical Operating income of $14.5 million, or 4.0% of net sales, adjusted OI of 4.8%, up 140 bps year-over-year Net income of $10.1 million, or $0.40 per diluted share, adjusted EPS of $0.49, more than double Q1 fiscal 2025 Cash from operations of $8.1 million, the seventh consecutive quarter of positive cash generation Debt of $138.0 million, down $9.5 million in the quarter, and borrowing capacity of $294.3 million Cash Conversion Days of 83, the lowest level in 3 years Invested $1.5 million to repurchase 49,000 shares of common stock Kimball Electron
Kimball Electronics, Inc. (NASDAQ:KE) today announced that it will report first quarter fiscal year 2026 financial results on Wednesday, November 5, 2025, after the closing of the market. The company will host a conference call and live webcast to review the results on Thursday, November 6, 2025, at 10:00 a.m. Eastern Time. The telephone number to access the conference call is 888-396-8049 / +1 416-764-8646. A live webcast of the conference call can be accessed at investors.kimballelectronics.com. For those unable to participate in the live webcast, a replay will be archived at investors.kimballelectronics.com. About Kimball Electronics, Inc. Kimball Electronics is a global, multif
Fourth Quarter 2025 Highlights Net sales totaled $380.5 million, a 2% sequential increase compared to Q3 Operating income of $16.5 million, or 4.3% of net sales Adjusted operating income of $19.6 million, or 5.2% of net sales Inventory of $273.5 million, a reduction of $23.1 million in the quarter Cash generated from operating activities of $78.1 million, the sixth consecutive quarter of positive cash flow Borrowings on credit facilities of $147.5 million, a $31.3 million decrease from Q3 Cash Conversion Days of 85, the lowest result in three years Kimball Electronics, Inc. (NASDAQ:KE) today announced financial results for the fourth quarter and fiscal year ended Jun
SC 13G/A - Kimball Electronics, Inc. (0001606757) (Subject)
SC 13G/A - Kimball Electronics, Inc. (0001606757) (Subject)
SC 13G/A - Kimball Electronics, Inc. (0001606757) (Subject)
Kimball Electronics, Inc. (NASDAQ:KE) today announced the Company is intensifying its focus on strategic development with the appointment of a new member to its leadership team. Andrew D. Regrut, Treasurer and Investor Relations Officer, will now also lead the strategic development efforts of the Company. Commenting on Mr. Regrut's expanded role, Jana T. Croom, Chief Financial Officer, stated, "I'm thrilled to be announcing Andy's promotion and addition to our leadership team. He has been instrumental in our recent efforts to optimize debt levels through improved working capital management and global cash movement. We look for his energy and intensity to elevate our focus on strategic d
Strategic healthcare leader brings more than 30 years of global experience to PureTech's Board following notable positions with Cardinal Health, Teva Pharmaceuticals and McKinsey & Company PureTech Health plc (NASDAQ:PRTC, LSE: PRTC))) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announced that Michele Holcomb, PhD, will join its board of directors as an independent non-executive director. Dr. Holcomb's appointment will take effect as of September 23, 2024. She brings more than 30 years of expertise leading global healthcare companies through strategic inflection points and preparing in
600 new employees will be based in Asia and the U.S., with offices in Vietnam, China, India, Japan and Silicon Valley. MONTREAL, Aug. 1, 2024 /PRNewswire/ - Averna, a leading global test & quality solutions provider, announced the acquisition of Global Equipment Services, Inc. (GES), a division of Kimball Electronics, Inc. (NASDAQ:KE) specialized in automation, test and measurement solutions for industries such as consumer electronics, semiconductor and medical devices. This strategic acquisition combines both companies' strengths and footprint to create one of the largest in